Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Read More

Overview

Feature Articles

Latest Prostate Cancer News and Research

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

New viable therapeutic strategy found for ER+ breast cancer

New viable therapeutic strategy found for ER+ breast cancer

Potential new method of breast cancer treatment using androgen receptor

Potential new method of breast cancer treatment using androgen receptor

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

New approach shows promise as a treatment for chemo-resistant ovarian cancer

New approach shows promise as a treatment for chemo-resistant ovarian cancer

New framework to help guide decisions for prostate cancer radiotherapy during COVID-19 pandemic

New framework to help guide decisions for prostate cancer radiotherapy during COVID-19 pandemic

Experimental heart disease drug may treat chemo-resistant ovarian cancer

Experimental heart disease drug may treat chemo-resistant ovarian cancer

Highly focused radiation may slow disease progression in men with oligometastatic prostate cancer

Highly focused radiation may slow disease progression in men with oligometastatic prostate cancer

Intense and targeted radiotherapy could slow progression of certain prostate cancers

Intense and targeted radiotherapy could slow progression of certain prostate cancers

Overexpression of hPCL3S could contribute to tumor progression in prostate cancer

Overexpression of hPCL3S could contribute to tumor progression in prostate cancer

NYUAD researchers develop new microfluidic platform to perform cancer liquid biopsies

NYUAD researchers develop new microfluidic platform to perform cancer liquid biopsies

Study identifies ancestral fragments of DNA associated with hereditary prostate cancer

Study identifies ancestral fragments of DNA associated with hereditary prostate cancer

Older cancer patients taking multiple medications are at higher risk of hospitalization

Older cancer patients taking multiple medications are at higher risk of hospitalization

Researchers discover why some prostate cancers are more aggressive

Researchers discover why some prostate cancers are more aggressive

People with a cancer history have increased risk of developing atrial fibrillation

People with a cancer history have increased risk of developing atrial fibrillation

African-American men less likely to use more targeted biopsy option for prostate cancer

African-American men less likely to use more targeted biopsy option for prostate cancer

Researchers uncover clues to how statins kill cancer cells

Researchers uncover clues to how statins kill cancer cells

Blood test for microbial DNA could warn of cancer

Blood test for microbial DNA could warn of cancer

Exercise works for prostate cancer sufferers starting treatment

Exercise works for prostate cancer sufferers starting treatment